1. Performance of a high-sensitivity rapid diagnostic test for Plasmodium falciparum malaria in asymptomatic individuals from Uganda and Myanmar and naive human challenge infections
- Author
-
Das, S, Jang, IK, Barney, B, Peck, R, Rek, JC, Arinaitwe, E, Adrama, H, Murphy, M, Imwong, M, Ling, CL, Proux, S, Haohankhunnatham, W, Rist, M, Seilie, AM, Hanron, A, Daza, G, Chang, M, Nakamura, T, Kalnoky, M, Labarre, P, Murphy, SC, McCarthy, JS, Nosten, F, Greenhouse, B, Allauzen, S, and Domingo, GJ
- Subjects
Diagnostic Tests, Routine ,Reverse Transcriptase Polymerase Chain Reaction ,Plasmodium falciparum ,Protozoan Proteins ,Infant ,Antigens, Protozoan ,Enzyme-Linked Immunosorbent Assay ,Articles ,Myanmar ,Sensitivity and Specificity ,Specimen Handling ,Child, Preschool ,parasitic diseases ,Humans ,Uganda ,Malaria, Falciparum ,Child ,Asymptomatic Infections - Abstract
Sensitive field-deployable diagnostic tests can assist malaria programs in achieving elimination. The performance of a new Alere™ Malaria Ag P.f Ultra Sensitive rapid diagnostic test (uRDT) was compared with the currently available SD Bioline Malaria Ag P.f RDT in blood specimens from asymptomatic individuals in Nagongera, Uganda, and in a Karen Village, Myanmar, representative of high- and low-transmission areas, respectively, as well as in pretreatment specimens from study participants from four Plasmodium falciparum-induced blood-stage malaria (IBSM) studies. A quantitative reverse transcription PCR (qRT-PCR) and a highly sensitive enzyme-linked immunosorbent assay (ELISA) test for histidine-rich protein II (HRP2) were used as reference assays. The uRDT showed a greater than 10-fold lower limit of detection for HRP2 compared with the RDT. The sensitivity of the uRDT was 84% and 44% against qRT-PCR in Uganda and Myanmar, respectively, and that of the RDT was 62% and 0% for the same two sites. The specificities of the uRDT were 92% and 99.8% against qRT-PCR for Uganda and Myanmar, respectively, and 99% and 99.8% against the HRP2 reference ELISA. The RDT had specificities of 95% and 100% against qRT-PCR for Uganda and Myanmar, respectively, and 96% and 100% against the HRP2 reference ELISA. The uRDT detected new infections in IBSM study participants 1.5 days sooner than the RDT. The uRDT has the same workflow as currently available RDTs, but improved performance characteristics to identify asymptomatic malaria infections. The uRDT may be a useful tool for malaria elimination strategies.
- Published
- 2017